CIPLA
Cipla Limited
Pharmaceuticals · ₹1,16,467 Cr market cap
A leading pharmaceutical manufacturer, Cipla develops and markets branded and generic formulations alongside active pharmaceutical ingredients across multiple therapeutic areas. Established in 1935, the company operates manufacturing facilities across India and internationally, serving both domestic and global markets. Cipla's distinctive strength lies in its integrated business model combining formulation development with API production, enabling cost-efficient drug manufacturing, distribution, and accessibility to patients worldwide.
6
Tracked investors holding
0
Tracked moves
₹1,441
Share price
Top investors holding Cipla Limited
Plus 3 more tracked investors holding Cipla Limited. Sign in to see them all.
Sign in to view all holders